Literature DB >> 33186141

Toward Quantification: Microstructure and Magnetic Resonance Fingerprinting.

Valerij G Kiselev1, Gregor Körzdörfer2, Peter Gall2.   

Abstract

Quantitative magnetic resonance imaging (MRI) is a long-standing challenge. We advocate that the origin of the problem is the simplification applied in commonly used models of the MRI signal relation to the target parameters of biological tissues. Two research fields are briefly reviewed as ways to respond to the challenge of quantitative MRI, both experiencing an exponential growth right now. Microstructure MRI strives to build physiology-based models from cells to signal and, given the signal, back to the cells again. Magnetic resonance fingerprinting aims at efficient simultaneous determination of multiple signal parameters. The synergy of these yet disjoined approaches promises truly quantitative MRI with specific target-oriented diagnostic tools rather than universal imaging methods.

Year:  2021        PMID: 33186141     DOI: 10.1097/RLI.0000000000000738

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

1.  Reliable Assessment of Swine Renal Fibrosis Using Quantitative Magnetization Transfer Imaging.

Authors:  Kai Jiang; Christopher M Ferguson; Roger C Grimm; Xiangyang Zhu; James F Glockner; Lilach O Lerman
Journal:  Invest Radiol       Date:  2022-05-01       Impact factor: 6.016

2.  An efficient approach to optimal experimental design for magnetic resonance fingerprinting with B-splines.

Authors:  Evan Scope Crafts; Hengfa Lu; Huihui Ye; Lawrence L Wald; Bo Zhao
Journal:  Magn Reson Med       Date:  2022-03-07       Impact factor: 3.737

3.  MR Fingerprinting-A Radiogenomic Marker for Diffuse Gliomas.

Authors:  Elisabeth Springer; Pedro Lima Cardoso; Bernhard Strasser; Wolfgang Bogner; Matthias Preusser; Georg Widhalm; Mathias Nittka; Gregor Koerzdoerfer; Pavol Szomolanyi; Gilbert Hangel; Johannes A Hainfellner; Wolfgang Marik; Siegfried Trattnig
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.